Decoupling Inherent Risk and Early Cancer Signs in Image-based Breast
  Cancer Risk Models by Liu, Yue et al.
Decoupling Inherent Risk and Early Cancer
Signs in Image-based Breast Cancer Risk Models
Yue Liu1,2( ), Hossein Azizpour1, Fredrik Strand3,4, and Kevin Smith1,2
1 KTH Royal Institute of Technology, Stockholm, Sweden
yue3@kth.se
2 Science for Life Laboratory, Solna, Sweden
3 Karolinska Institutet, Stockholm, Sweden
4 Karolinska University Hospital, Stockholm, Sweden
Abstract. The ability to accurately estimate risk of developing breast
cancer would be invaluable for clinical decision-making. One promising
new approach is to integrate image-based risk models based on deep
neural networks. However, one must take care when using such models,
as selection of training data influences the patterns the network will
learn to identify. With this in mind, we trained networks using three
different criteria to select the positive training data (i.e. images from
patients that will develop cancer): an inherent risk model trained on
images with no visible signs of cancer, a cancer signs model trained on
images containing cancer or early signs of cancer, and a conflated model
trained on all images from patients with a cancer diagnosis. We find
that these three models learn distinctive features that focus on different
patterns, which translates to contrasts in performance. Short-term risk
is best estimated by the cancer signs model, whilst long-term risk is best
estimated by the inherent risk model. Carelessly training with all images
conflates inherent risk with early cancer signs, and yields sub-optimal
estimates in both regimes. As a consequence, conflated models may lead
physicians to recommend preventative action when early cancer signs are
already visible.
Keywords: Mammography · Risk prediction · Deep learning
1 Introduction
Breast cancer is the most commonly occurring type of cancer worldwide for
women [1]. An effective method to reduce breast cancer mortality is to detect
it early while it is still curable. Population-wide mammographic screening is
proven to have a positive effect in this regard, and has been implemented across
many developed countries [2]. However, studies have shown that mammographic
screening has limited sensitivity for some women [3]. Cancers that could poten-
tially be found with more sensitive screening methods are routinely missed. For
example, adding MRI or ultrasound screening would improve early detection,
but are too costly to offer to the whole population. A reliable method to esti-
mate breast cancer risk would allow hospitals to offer more personalized care to
high-risk women, including enhanced screening and other preventive measures.
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Fig. 1. If trained carelessly, conflated (blue) neural networks confound long-term in-
herent risk (orange) and early cancer signs (red). Top: Test AUC of the models (based
on 20% of the positive samples and all negative samples), computed every 7 days over
an 8-year period using a sliding window of varying width (shaded areas show 95% con-
fidence interval). Bottom: Number of positive exams in the test set (women who will
develop cancer) vs. time until diagnosis. Spikes correspond to scheduled screenings. The
right-most bin contains 255 exams. The gray region shows when the sliding window
contains samples ≤30 days to diagnosis, which likely corresponds to screen-detected
cancers. The conflated model, trained on all images, is decoupled into inherent risk
and cancer signs. All three models outperform the mammographic density baseline.
Short-term risk is best estimated by the cancer signs model, which is unsurprising as
it was trained like a cancer detector. Long-term risk is best estimated by the inherent
risk model, whose AUC remains constant even near diagnosis. Although the conflated
model was trained with more data, it is sub-optimal in both the short- and long-term.
Breast cancer risk prediction approaches include questionnaire-based mod-
els such as Gail and Tyrer-Cuzick models [4, 5] and breast density models. A
new state-of-the-art in breast cancer risk estimation was recently established
using deep neural networks trained on mammograms [6, 7]. These risk models
represent a paradigm shift towards learned features, and have been shown to
substantially outperform prior models. Based on these successes, we anticipate
that risk assessment research will shift towards deep learning approaches.
The key message of this work is a warning that, if care is not taken when
selecting the training data and designing the training procedure, neural networks
trained to estimate breast cancer risk may conflate actual risk prediction and
cancer detection. Conflated models purport to perform long-term risk prediction,
but in reality are highly sensitive to cancer signs. This yields sub-optimal long-
term risk estimation, and could cause cancers to go undetected if physicians
believe women have high long-term risk when in fact they exhibit cancer signs.
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Through a series of experiments, we illustrate the phenomenon of risk con-
flation both qualitatively and quantitatively, and measure how it impacts the
performance of risk prediction over time. Code to reproduce our work is avail-
able at https://github.com/yueliukth/decoupling_breast_cancer_risk.
2 Related Works
Breast cancer prevention demands accurate and individualized risk assessment
for decision-making. Over the last decades, many models for estimating individ-
ual breast cancer risk have been developed. The Gail model [4] is a questionnaire-
based method for estimating 5-year and lifetime risk of developing invasive
breast cancer. It considers risk factors such as a woman’s age and family history.
Tyrer–Cuzick [5], another commonly-used risk model, incorporates more detailed
family history. Glynn et al. recently compared questionnaire-based models and
found that their practical usefulness is limited by performance [8].
Breast density, aside from age, is one of the strongest risk factors for breast
cancer [9]. Density measures if a breast is more fatty or contains more fibroglan-
dular tissue, can be obtained from mammographic screens, and has been shown
to improve questionnaire-based models [10]. Density is often defined by a few
statistics obtained either through ad-hoc [11] or learning-based approaches [12].
In general, methods for quantifying density lack consistency [13] and tend to
over-simplify image data, limiting their general application.
In the era of deep learning, most research in mammography has focused on
computer-aided diagnosis (CAD) [14–16]. A handful of studies have addressed
risk prediction, though most have been restricted to small datasets and short-
term prediction. Two such studies [17, 18] considered a few hundred negative
screening samples, and predicted which would be positive at the next screening.
He et al. used a multi-modal approach to combine mammographic screenings,
ultrasound images, patient demographics, and language from clinical reports to
predict if a patient with an abnormal mammogram should be sent for biopsy [19].
Two recent breakthrough studies showed substantial improvements in long-
term risk prediction using neural networks on large population-level cohorts.
Yala et al. showed mammogram-based deep learning models outperform the
Tyrer–Cuzick model for five-year risk prediction [6]. Dembrower et al. similarly
showed that five-year risk predictions from a neural network surpass density-
based predictions [7]. In this study, we consider the same cohort as Dembrower
et al., but our focus is not to push performance, rather to raise awareness of the
dangers of conflating long-term risk and cancer signs in risk models.
3 Decoupling Breast Cancer Risk
A straightforward approach to train a network to predict breast cancer risk
from mammograms is to provide all images from cancer patients as positive
examples. Several prior works have trained models in this manner. The problem
with this approach is that the images recorded near the date of diagnosis are
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Fig. 2. We decouple inherent risk (orange) and cancer signs (red) from the conflated
model by splitting the positive training data in two separate parts. Top: Histogram
of positive ipsilateral images over the study period (ipsilateral is the the breast that
develops cancer). A cutoff of 1 year from diagnosis (dashed line) separates images with
no visible cancer signs (orange) from those with possible cancer signs (red). Bottom:
Positive contralateral images, from the other breast that is usually confirmed cancer-
free. As it has been exposed to the same environmental and genetic risk factors as the
ipsilateral, it is included in the inherent risk model. The conflated risk model is trained
with all images. The cancer signs model is trained with red-marked positive examples,
while the inherent risk model is trained with orange-marked positive examples.
included in the positive set, and are likely to include signs of actual cancer. We
can imagine separating the positive training images with no visible cancer signs
from those containing cancer signs by drawing an arbitrary cutoff within one
screening interval, e.g. at one year from diagnosis (Fig. 2). From this perspective,
the data contains two different classification problems: inherent risk vs. healthy
and cancer signs vs. healthy. When we train using all the data, we conflate them
into a single binary classification task, at-risk vs. healthy.
This is problematic for the learning process, since recognizing long-term risk
is more difficult than detecting cancer signs. Networks are known to converge
faster with easier examples [20, 21], and if it focuses too strongly on increasing
confidence of the easy samples [22] learning on the harder long-term risk problem
may be crippled.
Consequently, we hypothesize that the conflated model will perform worse at
long-term risk prediction than a model trained exclusively with images acquired
before onset of early cancer signs. This effect will be more acute when a sub-
stantial portion of the positive data contains cancer signs, which is typical for
population datasets (for CSAW [23], up to 31% of the positive samples may con-
tain cancer signs). In order to test this hypothesis, we decomposed the conflated
model by dissecting the data and training models on those splits. We trained
an inherent risk model using data with no visible cancer signs, and a cancer
signs model using data that contains a substantial number of cancer signs. The
conflated model was provided with all available data.
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Table 1. Model Performance of Risk Prediction on Test Set
AUC (95% CI)
31d – 1 year >1 year >2 years >5 years
Inherent risk 0.62 (0.62, 0.63) 0.62 (0.61, 0.62) 0.62 (0.61, 0.62) 0.61 (0.60, 0.62)
Cancer signs 0.71 (0.68, 0.73) 0.59 (0.58, 0.60) 0.59 (0.58, 0.59) 0.56 (0.55, 0.57)
Conflated 0.72 (0.69, 0.75) 0.61 (0.60, 0.62) 0.60 (0.59, 0.61) 0.58 (0.56, 0.59)
Density 0.61 (N/A) 0.54 (N/A) 0.54 (N/A) 0.55 (N/A)
Details of the data selection strategy are provided in Fig. 2. For ipsilateral –
breasts that will develop cancer – we selected a cutoff of one year prior to diag-
nosis to separate inherent risk and cancer signs (dashed line). The contralateral
breast is usually confirmed cancer-free in patients with breast cancer. It reflects
actual risk without revealing any cancer cues, as it has been exposed to the same
environmental and genetic risk factors. Therefore, we included the contralateral
breast in the inherent risk model but not the cancer signs model.
Using these models, we conducted a series of experiments to understand the
phenomenon of risk conflation. We address the following questions:
1. How does the conflated model compare to the decoupled models over time?
2. Does the conflated model identify the same at-risk women as the inherent
risk/cancer signs models?
3. Do the inherent risk/cancer signs models recognize the same patterns?
4 Experimental Setup
Dataset The dataset used in our study is extracted from CSAW, a population-
based screening cohort containing millions of mammographic images [23]. Mam-
mograms of multiple views were collected every 18 to 24 months from women
aged 40 to 74. Outcome and date of diagnosis was determined through the Re-
gional Cancer Center Registry. The data was curated by excluding images from
patients with implants, biopsy images, or other issues such as aborted exposure.
We randomly assigned the participants to the training, validation and test set.
Negative exams were randomly sampled among women with at least two years’
cancer-free follow-up. A flowchart describing the data curation is given in Sup-
plementary Figure 1. The resulting training set contains 138,032 mammograms
from 15,558 women, the validation set contains 3,008 mammograms from 332
women, and the test set contains 6,436 mammograms from 731 women.
Preprocessing The source images are in standard DICOM format. Using DI-
COM metadata, we flip images horizontally to make all breasts left-posed. We
rescale the intensity to the range defined in the acquisition metadata [24], and we
detect and correct inverted contrast images using the photometric attribute. We
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Fig. 3. Venn diagrams showing true positive rates of various models, given their top-5%
predictions. The inherent risk (orange) model consistently identifies decidedly different
sets of at-risk women, compared to the cancer signs (red) model. The conflated (blue)
model identifies nearly the exact same positive images as the cancer signs model near
the date-of-diagnosis. But farther from diagnosis it overlaps both decoupled models.
perform a rough alignment of each image using a distance transform to locate the
center of mass. Zero-padding is applied to ensure all images have uniform size,
then images are resized to 632 × 512. This ensures each image retains relative
scale and aspect ratio. Finally, the images are converted to 16-bit PNG format.
Implementation details We use the same architecture and training setup for
all models. In particular, we use ResNet50 [25] with group normalization [26],
and replace standard ReLU activation with Leaky-ReLU [27]. We use binary
cross-entropy loss and batch size of 32 with a stochastic gradient descent with
momentum (SGDM) optimizer. All models were initialized with ImageNet pre-
trained weights [28]. We employ standard data augmentation including random
rotation, crops, brightness and contrast. Hyperparameters detailed below were
selected using grid search. The initial learning rate for the cancer signs and con-
flated models is 0.0001, and 0.001 for the inherent risk model. The inherent risk
and conflated models were run for 50 epochs, and the learning rate was lowered
by a factor of 10 at epoch 20. The cancer signs model was run for 100 epochs,
with a similar learning rate drop at epoch 50. Dropout [29] with a rate of 0.5
was applied after the last fully connected layer in the inherent risk model.
We repeated each experiment five times and report the mean, unless other-
wise specified. As a baseline, we provide risk estimation results using mammo-
graphic density (breast dense area) from publicly available software, LIBRA [30].
5 Results and Discussion
Through a series of experiments based on the setup described above, we address
the questions raised in Section 3.
Conflated risk model vs. decoupled models We find that the conflated
model is a weakened hybrid of the inherent risk and cancer signs models. It un-
derperforms the decoupled models in both short- and long-term risk prediction.
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Fig. 4. Grad-CAM visualizations suggest that the inherent risk model and cancer signs
model base their decisions on different image cues. Top: CC views of a breast that
develops cancer over 4 years. An expert cancer annotation (red region) appears in the
most recent image, and the cancer-developing location is identified in the prior image
(red dot). Time-to-diagnosis (t.t.d., in years) and risk prediction yˆ are provided for
each image. Bottom: Grad-CAM visualizations. The activation maps are weighted by
the prediction score. The inherent risk model appears to rely on a broad range of image
cues, while the cancer signs model concentrates activations on tumor-like patterns.
In Fig. 1 we plot the exam-level AUC for our three models along with the den-
sity baseline. The x-axis shows how performance varies with time-to-diagnosis
using a sliding window. Exam-level predictions are the maximum breast risk
score; breast scores are the average score of both views. Near diagnosis, the can-
cer signs model is the best risk estimator. This is unsurprising because it was
trained like a tumor detector, and many of the positive mammograms within the
first year, especially within the first 30 days, are screen-detected cancers with vis-
ible tumors. Long-term risk is best estimated by the inherent risk model, whose
AUC remains constant, even in the first year. This suggests that the inherent risk
model has the desirable property of ignoring early cancer signs5 and focusing on
cues correlated with long-term risk, which do not change near time-of-diagnosis.
Similar conclusions can be drawn from Table 1, where we break down risk
prediction by short-term and long-term outlooks. Inherent risk performs best at
long-term risk prediction, while the cancer signs/conflated models show similar
performance in the short-term (bold values indicate significant improvements;
statistical tests can be found in Supplementary Table 1).
Identifying at-risk women An important clinical question is: do these models
identify the same at-risk women? To test this, we consider images identified by
the top-5% predictions of each model – a number chosen to reflect the capacity
5 Cancer detection is the purview of established screening routines or CAD systems.
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Fig. 5. Localization of gradient-weighted class activation maps (Grad-CAM) from
Fig. 4, computed over all positive test images (x-axis indicates time until diagnosis).
Lines are the mean computed from five models, shaded areas indicate the 95% CI.
The cancer signs (red) model exhibits more localized activations, measured by total
variation (TV) norm of Grad-CAMs. The inherent model (orange) consistently cov-
ers a larger area, indicating that the two models concentrate on different patterns. A
sharp dip near time-of-diagnosis in the ipsilateral cancer signs model suggests that it
concentrates on tumor-like patterns, as these images are likely to contain visible cancer.
of a healthcare system for additional screening. In Fig. 3 we compare positive-
identified images from all three models. The inherent risk model consistently
identifies different images than the cancer signs model, supporting our hypoth-
esis that it focuses on different cues. Near the date-of-diagnosis, the conflated
model highly overlaps with the cancer signs model, but farther from diagnosis
it overlaps both decoupled models. Its proportion of novel at-risk findings is
consistently low, suggesting it could be replaced by the decoupled models.
Image cues that indicate risk The final question we address is: do the decou-
pled models recognize different patterns? This is a difficult question to answer
conclusively, but we can gain some insight by understanding and quantifying
where the network pays attention.
In Fig. 4 we visualize how gradient-weighted class activation maps (Grad-
CAM) [31] of the inherent risk and cancer signs models evolve over time. Quali-
tatively, we can see that the cancer signs model exhibits sharp activations local-
ized to the tumor, whereas the inherent risk model has broad activations in the
center of the breast. We empirically confirm this trend over the entire positive
test set by computing the total variation of the Grad-CAM heatmaps in Fig. 5,
and using multi-scale blob detection [32] in Supplementary Figure 2. Based on
these results, we surmise that the inherent risk model relies on a broader range
of image cues than the cancer signs model, which appears to concentrate acti-
vations near tumor-like patterns.
6 Conclusions
Our key finding is that risk estimation models conflate inherent risk and cancer
signs if care is not taken during training. We demonstrate that conflated models
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can be decoupled by selecting appropriate training data, and that the decoupled
models consistently outperform the conflated model, even though it is trained
with more data. In particular, short-term risk (≤1 year in our study) should rely
on cancer sign models. Long-term risk models should be trained exclusively on
images with no visible cancer signs, or use other strategies to mitigate model
conflation. When models are put to clinical use, it is important to state which
type of model is used, or to somehow assist in the interpretation of conflated
models – otherwise physicians may believe that a woman has high long-term
risk when, in fact, her images already exhibit cancer signs. Our hope is that this
work will provide valuable insights for the development and clinical translation
of deep neural networks for cancer risk estimation.
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A Appendix
Fig. 6. Data selection flowchart. There were 245,514 images from 19,709 women in
the source data extracted from CSAW, which included all positive cases and a ran-
dom sampling of negative cases. We excluded patients with implants, biopsy im-
ages and images with other issues. After randomly splitting the remaining images
into train/validation/test sets, we excluded risk-negative exams without a cancer-free
follow-up screening within two years. The resulting dataset includes 138,032 mammo-
grams from 15,558 women, 3,008 mammograms from 332 women, 6,436 mammograms
from 731 women in the training/validation/test sets.
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Table 2. Statistical tests for differences between model predictions
p-value (two-sided t-test)
31d – 1 year >1 year >2 years >5 years
Conflated / inherent risk <0.001 0.063 0.007 0.002
Conflated / cancer signs 0.546 0.020 0.014 0.101
Cancer signs / inherent <0.001 <0.001 <0.001 <0.001
Fig. 7. Multi-scale blob detection on gradient-weighted class activation maps (Grad-
CAM) from Fig. 4 in the main text, computed over all positive test images (x-axis
indicates time until diagnosis). Using highest response of a Laplacian-of-Gaussian filter
at multiple scales, the radius of the largest detected blob from each positive image was
recorded. Activations from the inherent risk model are consistently larger, suggesting
it focuses on a broader range of features than the cancer signs model.
